Macro Margaret - Department of Hematology, University Hospital

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 186 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti-CD38 Antibodies: the EMMY Cohort from 2017 to 2020

Laure Vincent,Olivier Decaux,Aurore Perrot,Bruno Royer,Thomas Chalopin,Arthur Bobin,Margaret Macro,Denis Caillot,Lionel Karlin,Caroline Jacquet, Cécile Sonntag,Mohamad Mohty,Laurent Frenzel,Arnaud Jaccard,Salomon Manier,Laurence Sanhes,Driss Chaoui,Philippe Moreau, Ronan Garlantézec,Nathalie Texier, Chanaz Louni, Zakaria Maarouf,Herve Avet Loiseau,Cyrille Hulin, Karim Belhadj Merzoug

Cancer medicineno. 6 (2025): e70619-e70619

Cited0Views0WOSBibtex

Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results

Jill Corre,Laure Vincent,Philippe Moreau,Benjamin Hebraud,Cyrille Hulin,Marie-Christine Béné,Annemiek Broijl,Denis Caillot,Michel Delforge,Thomas Dejoie,Thierry Facon,Jerome Lambert,Xavier Leleu,Margaret Macro,Aurore Perrot,Sonja Zweegman,Thomas Filleron, Bastien Cabarrou,Niels W C J van de Donk, Sabrina Mahéo, Winnie Hua,Jianping Wang,Maria Krevvata, Véronique Vanquickelberghe, Carla de Boer, Alba Tuozzo, Fredrik Borgsten, Melissa Rowe, Robin Carson,Soraya Wuilleme,Pieter Sonneveld

Blood (2025)

Cited0Views0WOSBibtex

All-oral Triplet Iberdomide, Ixazomib, and Dexamethasone in Elderly Patients with Multiple Myeloma at First Relapse: Results of the IFM Phase 2 Study I2D

Journal of Clinical Oncologyno. 16_suppl (2024): 7507-7507

Cited0Views0Bibtex

The EMMY Longitudinal, Cohort Study: Real-World Data to Describe Multiple Myeloma Management and Outcomes As More Therapeutic Options Emerge

Clinical Hematology Internationalno. 3 (2024)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn